Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

September 14, 2016Open Access

Ver artículo completo

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

ACAnthony L. CunninghamSouth Australia Pathology HLHimal LalPfizer (United States)MKMartina KovacPharmaceutical Product Development (United States)

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

In our trial, HZ/su was found to reduce the risks of herpes zoster and postherpetic neuralgia among adults 70 years of age or older. (Funded by GlaxoSmithKline Biologicals; ZOE-50 and ZOE-70 ClinicalTrials.gov numbers, NCT01165177 and NCT01165229 .).

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Cunningham et al. (Wed,) studied this question.

synapsesocial.com/papers/69e001ba93e101b251e9c5a4 https://doi.org/https://doi.org/10.1056/nejmoa1603800

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Antivirals for Management of Herpes Zoster Including Ophthalmicus: A Systematic Review of High-Quality Randomized Controlled Trials2011 · 59 citations
2Humoral and Cellular Immunity to Varicella‐Zoster Virus: An Overview2008 · 182 citations
3The management of post-herpetic neuralgia2000 · 91 citations
4Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study2014 · 215 citations
5Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia2015 · 97 citations